IntelliMed Healthcare Solutions

What IntelliMed Healthcare Solutions does

IntelliMed Healthcare Solutions is an outsourced medical affairs services company founded in 2020 as the medical affairs partnering division of Wellesta Group, a diversified healthcare conglomerate with operations across India, Southeast Asia, and Europe. Headquartered in Mumbai with a regional office in Singapore (IntelliMedEsta Pte Ltd) and European reach via Wellesta Europe, the firm serves Indian and multinational pharmaceutical, medical device, nutraceutical, and digital healthcare companies with a 22-person team of MD, PharmD, MPharm, PhD, and BDS-qualified professionals. The company delivers six interconnected core service lines: Medical Communication and Information Services, Research and Evidence Generation (including Real World Evidence and an e-CRF platform), Regulatory and Pharmacovigilance, Medical Science Liaison (MSL) services, Patient Support/Assistance Programs (PSP/PAP), and end-to-end Outsourced/Contract Medical Affairs (CMA).

The portfolio is built around a '4D' framework (Differentiation, Diligence, Data, Dissemination) and a product lifecycle management approach spanning brand introduction, growth, maturity, and lifecycle extension stages. Technical components include a proprietary e-CRF platform and virtual CRC capabilities for clinical data management, though the core value proposition is human expertise rather than software. The company reports 115 active statements of work, multiple drug evaluations, peer-reviewed publications in Frontiers, Springer, and PMC-indexed journals, and ongoing Real World Evidence studies involving HCPs.

Revenue is generated through project-based contracts, statements of work, and retainer arrangements with enterprise healthcare clients under a professional services commercial model. Pricing is custom-quoted based on project scope, duration, and resource requirements. Distribution is via direct enterprise sales engagement, with cross-region reach enabled by the Wellesta Group platform. Leadership is anchored by founder and CEO Dr. Anish Desai (ex-J&J, Bayer, BMS, Unichem, Glenmark, UCB), with Milan Paleja as Chairman of the parent Wellesta Group. The firm has received 2024 Best Place to Work recognition from The Times of India and Economic Times. No external institutional funding is disclosed.

Name

IntelliMed Healthcare Solutions

Legal name

IntelliMedEsta Pte Ltd

Website

https://intellimed.org

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

IntelliMed Healthcare Solutions is the medical affairs outsourcing arm of Wellesta Group, providing contract medical affairs, MSL, medical writing, regulatory, pharmacovigilance, evidence generation, and patient support services to pharma, medical device, nutraceutical, and digital health companies across India, Southeast Asia, and Europe.

Ownership category

akta.pro rank

Product category

Medical Affairs Services / Healthcare Consulting

NAICS

Other Scientific and Technical Consulting Services (54169), Scientific Research and Development Services (5417)

SIC

Services-Health Services (8000)

akta.pro primary industry

Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)

Keywords

• Medical affairs services
• Pharmaceutical consulting
• Regulatory affairs support
• Clinical evidence generation
• Medical science liaison

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Contract Medical Affairs Services: IntelliMed provides outsourced medical affairs services to pharmaceutical, biotech, nutraceutical, and medical device companies on a contract basis. Services include medical writing, MSL deployment, regulatory support, pharmacovigilance, evidence generation, and patient support programs. Revenue is generated through project-based contracts, statement of work engagements (115 active SOWs mentioned), and retainer arrangements for ongoing medical affairs support.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

IntelliMed Healthcare Solutions provides outsourced, contract-based Medical Affairs services to pharmaceutical, biotechnology, medical device, nutraceutical, and digital healthcare companies. Its offerings span Medical Communication, Research & Evidence Generation, Regulatory & Pharmacovigilance, Medical Science Liaison (MSL) deployment, Patient Support Programs, and end-to-end Contract Medical Affairs resourcing, delivered by a team of medically qualified (MD, PharmD, PhD) professionals across India and the wider APAC region.

Product overview

IntelliMed Healthcare Solutions is a Medical Affairs partnering company offering a comprehensive suite of outsourced/Contract Medical Affairs (CMA) services to pharmaceutical, medical device, nutraceutical, and digital healthcare companies. The portfolio comprises six interconnected core service offerings: Medical Communication & Information Services (manuscript writing, publications, CMEs, sales force training), Research & Evidence Generation Services (Real World Evidence studies, e-CRF platform, statistical analysis), Regulatory & Pharmacovigilance Services, Medical Science Liaison (MSL) Services, Patient Support/Assistance Programs (PSP/PAP), and end-to-end Outsourced/Contract Medical Affairs (CMA) covering product lifecycle management from launch through maturity. Together these services address the full spectrum of Medical Affairs needs across India, MNC clients, and diverse healthcare industry segments including pharmaceuticals, medical devices, digital healthcare, and nutraceuticals.

Differentiator

Problem solved

Functional benefit

Products and services

• Medical Communication Outsourced medical communications service for pharmaceutical, biotech, medical device, nutraceutical, and digital health companies, providing scientific content development, KOL engagement materials, and dissemination support across therapy areas.
• Research & Evidence Generation Clinical research and evidence generation services, including study design support and evidence synthesis, leveraging IntelliMed's e-CRF platform and virtual Clinical Research Coordinator (CRC) capability for remote and digitally driven study execution.
• Regulatory & Pharmacovigilance Regulatory affairs and pharmacovigilance services supporting life-sciences clients across APAC, including regulatory documentation, submission support, and safety/pharmacovigilance oversight for marketed and pipeline products.
• Medical Science Liaison (MSL) Services Outsourced deployment of Medical Science Liaisons to pharmaceutical and biotech clients, providing field-based scientific engagement with key opinion leaders, healthcare professionals, and investigators across therapy areas and geographies.
• Patient Support Programs Patient Support Programs (PSP) and Patient Assistance Programs (PAP) designed and operated on behalf of pharmaceutical sponsors to improve treatment access, adherence, and outcomes for patients.
• Contract Medical Affairs End-to-end outsourced Medical Affairs resourcing and execution delivered through IntelliMed's "4D" framework (Differentiation, Diligence, Data, Dissemination), enabling clients to flexibly scale medical-affairs capacity without permanent headcount expansion.

Quantifiable outcome

• 115 active statements of work across clients
• +3 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Wellesta GroupcoreStrategic or Co-development PartnerIntelliMed operates as part of the Wellesta Group of Companies, which operates across SEA, India, and Europe. The partnership provides strategic alignment and integrated healthcare solutions including medical affairs, commercial services, and market access support. Wellesta Group is the parent organization providing corporate infrastructure and regional expansion capabilities.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Envision Pharma Group: Medical communications, publications, and strategic medical affairs services for biopharma. Comparable scientific content and MSL support offerings.
• Real Chemistry: Healthcare marketing, communications, and medical affairs consultancy serving pharma and biotech. Comparable medical communications and HCP engagement capabilities.
• Complete HealthVizion: Medical publications, communications, and scientific content provider for pharma. Comparable specialization in scientific writing and publication planning.
• Indegene: India-based commercial and medical affairs outsourcing partner for global pharma, biotech, and devices. Direct peer with similar FSP/MSL model and emerging-market focus.
• OPEN Health: Specialized medical affairs, HEOR, and patient engagement services for pharma. Direct competitor in the medical communications and evidence-generation space.
• Cactus Communications: Scientific communications, medical writing, and publication support provider with strong India delivery backbone. Highly comparable service portfolio targeting pharma clients globally.

Broad incumbents

• ICON plc: Large global CRO with embedded medical affairs and scientific communications services. Represents broad incumbent competition for enterprise pharma clients.
• Parexel: Global CRO with medical communications, pharmacovigilance, and regulatory services. Competes in adjacent FSP-style engagements with large pharma.
• Syneos Health: Large CRO with dedicated medical affairs and commercial services. Represents broad incumbent competition in outsourced medical affairs FSP engagements.
• IQVIA: Global CRO and life sciences services giant offering medical affairs, MSL, and real-world evidence alongside its broader portfolio. Competes for large multi-region medical affairs contracts.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xlinkedin.com/company/intellimed-healthcare-solutions
• YouTubelinkedin.com/company/intellimed-healthcare-solutions
• LinkedInlinkedin.com/company/intellimed-healthcare-solutions
• Instagramlinkedin.com/company/intellimed-healthcare-solutions

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IntelliMed Healthcare Solutions